ClinicalTrials.Veeva

Menu

An Intervention Study on the Effect of Brazilian Spinach Supplementation on Health Outcomes Among Type 2 Diabetes Patients in Hospital Universiti Sains Malaysia

U

Universiti Sains Malaysia

Status

Completed

Conditions

Type 2 Diabetes Mellitus

Treatments

Dietary Supplement: Althernanthera Sissoo
Behavioral: Dietary Consultation

Study type

Interventional

Funder types

Other

Identifiers

NCT05727592
USM/JEPeM/20120630

Details and patient eligibility

About

The purpose of this study is to determine whether Brazilian spinach supplementation effective in improving the nutritional status of Type 2 Diabetes Mellitus patient.

Full description

Background: Vegetables are valuable health promotion foods because they contain vital nutrients such as vitamins, minerals, proteins, fibres and bio-functional components but are low in fat, sodium and calories as compared with many other foods. In terms of body fat, increase vegetable intake that consist of dietary fibre can play an important role in the regulation of body weight. Therefore, the supplementation of dietary fibre intake from vegetable may have benefit in reducing the percentages of body fat. Though, the clinical effect in human remains unclear and currently no study conducted in Malaysia regarding the effectiveness of this plant towards blood sugar control. Apart from that, lower intake of vegetable among Malaysian, lower cost vegetable choices and higher availability of Althernanthera Sissoo (Brazilian Spinach) due to easy growth may benefit the diabetes patient. Therefore, the investigators plan to conduct this study to determine the effectiveness of 12-weeks Brazilian Spinach supplementation on health outcomes among patients with type 2 diabetes especially in Kelantan region. The investigators hypothesized that diabetes patients on supplementation of Brazilian Spinach would have significant differ in terms of anthropometry, biochemical, clinical, and dietary intake compared to control group.

Method: A single-center randomized, controlled, and two-arm parallel design clinical trial will be carried out in Malaysia especially in Kelantan region. This study enrols 100 patients from Hospital Universiti Sains Malaysia (HUSM) diagnosed with type 2 diabetes. Diabetic patients who meet eligibility criteria will be randomly allocated to two groups, which are Brazilian Spinach treatment group and control group. Both groups will be compared on the primary and secondary outcomes at baseline, 3, 6, and 12 weeks.

Discussion: The study will provide insights into the potential beneficial effect of Brazilian Spinach in type 2 diabetic patients. In addition, the therapeutic effect of Brazilian Spinach towards type 2 diabetes will reflect as a change of metabolite profile in serum.

Enrollment

87 patients

Sex

All

Ages

30 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 30-65 years old
  • Have confirmed diagnosed with type 2 diabetes mellitus of equal or more than 6 months
  • HbA1c levels equal or more than 7% (within the last 3 months of recruitment)
  • On at least one oral hypoglycemic agent
  • Agree not to take other herbal or nutritional supplements for the duration of study.

Exclusion criteria

  • Unable to tolerate to fiber especially vegetables
  • Type 1 diabetes mellitus
  • Pregnant
  • Insulin treatment
  • Severe diabetic complications including end-stage renal diseases, liver diseases or gastrointestinal diseases
  • On coagulant therapy (warfarin)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

87 participants in 2 patient groups

Intervention Group
Experimental group
Description:
Intervention: Diabetic Brazilian spinach supplementation group Subjects in this group will be receiving Brazilian spinach for 12 weeks in which they must consume 15g of Brazilian spinach daily with lunch or dinner.
Treatment:
Dietary Supplement: Althernanthera Sissoo
Control Group
Experimental group
Description:
No intervention: Diabetic control group Subjects in this group will not receive Brazilian spinach. However, they will be receiving standard dietary counselling and educated for the same lifestyle intervention as in the intervention group.
Treatment:
Behavioral: Dietary Consultation

Trial contacts and locations

1

Loading...

Central trial contact

Juliana Shamsudin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems